Market Signal Briefing

TLDR Table of Contents

TLDRSOL Strategies Stock Jumps as Liquid Staking Gains TractionRevenue Growth Expands Across Staking OperationsGet 3 Free Stock Ebooks SOL Strategies stock rose 20.97% to $1.50 after the company released its February business update. The STKESOL liquid staking platform surpassed 691,000 SOL staked within weeks of launch. The platform attracted 1,034 holders shortly after its rollout. The validator network expanded to 33,568 unique wallets in February. Total assets under delegation reached 3.87 million SOL, including treasury and third-party stakes. SOL Strategies stock climbed 20.97% to $1.50 on Nasdaq after a strong February update. The company reported rapid growth in staking operations and liquid staking adoption. The update showed rising validator activity and expanding assets under delegation.

SOL Strategies Stock Jumps as Liquid Staking Gains Traction The company said its STKESOL liquid staking platform surpassed 691,000 SOL staked within weeks of launch. It also confirmed that 1,034 holders joined the platform during the initial rollout. The figures came from its February business update, which highlighted expanding validator activity and rising delegated assets.

SOL Strategies stated that its validator network reached 33,568 unique wallets in February. That figure increased from about 31,000 wallets at the start of the month. The company said STKESOL growth supported higher validator participation and stronger network engagement.

The firm reported total assets under delegation of 3.87 million SOL in February. This total included treasury holdings and tokens delegated by third parties. Proprietary validators generated about 1,276 SOL in rewards during the month.

The company confirmed that users, delegated assets, and staking rewards all increased during February. These metrics reflect performance across validator and staking services. The company linked this expansion directly to the rollout of liquid staking services.

SOL Strategies said liquid staking allows users to earn rewards while keeping tokens liquid. It issues tokenized staking positions that users can trade or deploy elsewhere. The company described this product as an added revenue channel beyond validator services.

Revenue Growth Expands Across Staking Operations Interim CEO Michael Hubbard said the company continues scaling infrastructure despite crypto market volatility. He stated, “The staking platform now has four revenue streams running simultaneously.” These include treasury staking, third-party delegated staking, liquid staking, and institutional staking services.

Hubbard confirmed partnerships form part of the institutional staking strategy. He cited a partnership with global asset manager VanEck as an example. The company reported that quarterly results rose 69% year on year.

Staking and validator rewards totaled 9,787 SOL during the quarter. This figure marked a 120% increase from the same quarter last year. The company linked this rise to expanded Solana-focused infrastructure operations.

SOL Strategies also reported growth in its Solana portfolio holdings. The portfolio increased to about 529,000 SOL from 139,726 previously recorded. The company attributed the rise to balance sheet growth and higher Solana exposure.

The February update included governance changes before the annual shareholder meeting on March 31. The company confirmed that Michael Hubbard will transition from interim to permanent CEO. SOL Strategies previously operated as Cypherpunk Holdings before rebranding in September 2024.

The company acquired SOL during the second quarter of 2024. It later rebranded to reflect its focus on Solana validators and staking services. SOL Strategies stock has declined 75.81% over the past six months despite the recent 21% rise.

Bitcoin (CRYPTO: BTC) has surged 7% since the start of the month as macro analyst Benjamin Cowen warned this mirrors the “bull trap” pattern that preceded massive sell-offs in every prior midterm cycle. The Midterm Bear Market Playbook Bitcoin is trading roughly 15% below its $87,500 yearly open, hitting the exact mathematical target for an early March relief rally.

XRP price is facing renewed selling pressure after a brief recovery attempt toward $1.45, with the price slipping back below $1.40 as broader crypto markets weaken. The pullback follows mild declines in major assets like Bitcoin and Ethereum, which have slightly cooled the recent market momentum.

From a broader perspective, XRP has repeatedly failed to sustain moves above $1.48, keeping the critical $1.50 resistance level out of reach. With the token now trading below $1.40, the key question is whether XRP will continue consolidating under $1.45 or gather enough strength to challenge the $1.50 barrier in the coming sessions.

As seen in the chart, XRP continues to trade below the local resistance at $1.48, which has emerged as a key barrier for the bulls. The price is currently consolidating near $1.41 while the broader trend remains confined within a descending parallel channel, indicating that the overall market structure is still bearish.

Within this structure, the $1.33 level acts as immediate support. A breakdown below this zone could accelerate the downside move, potentially dragging the price toward the lower boundary of the channel near $1.20–$1.15. 

From a momentum perspective, the Relative Strength Index (RSI) is gradually forming higher highs and higher lows, suggesting that buying pressure is slowly building. However, this momentum has not yet translated into a decisive price breakout. At the same time, the Accumulation/Distribution indicator continues to trend downward, signaling that capital inflows remain weak and that distribution pressure is still dominating the market.

For now, XRP remains at a critical technical junction.

A break and close above $1.48 could invalidate the short-term resistance and push the price toward $1.60, followed by $1.75 near the mid-channel resistance.
However, if the price loses the $1.33 support, XRP may extend the correction toward $1.20, with deeper support resting around $1.10–$1.05 near the lower trendline of the channel.
Until either level is decisively broken, XRP is likely to continue consolidating within the descending channel structure.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

TLDR: Table of Contents

TLDR:How xChange Bridges Traditional Markets and DeFixStocks Records Strong Growth Metrics Since June 2025Get 3 Free Stock Ebooks xChange is the first unified execution layer trading over 70 tokenized stocks across Ethereum and Solana onchain. Every xStock is backed 1:1 by underlying shares in custody, ensuring real equity exposure on the blockchain. Atomic settlement guarantees trades execute fully at the quoted price or not at all, eliminating partial fills. xStocks has surpassed $3.5 billion in onchain volume and 80,000 unique holders since launching in June 2025. xChange, the new unified execution layer from xStocks, is now live on Ethereum and Solana. The platform enables trading of more than 70 tokenized stocks directly onchain.

Pricing is anchored to real-world public market data, while atomic settlement ensures each trade completes fully or not at all.

Since its June 2025 launch, xStocks has recorded over $3.5 billion in onchain transaction volume, marking rapid adoption of tokenized equities.

How xChange Bridges Traditional Markets and DeFi xChange connects traditional market depth with decentralized finance infrastructure in one unified system. The platform does not rely on third-party intermediaries to process trades.

Instead, it executes transactions directly onchain across both Ethereum and Solana. This setup preserves the transparency and composability that DeFi participants expect.

Each xStock is fully collateralized and backed 1:1 by underlying shares held in custody. This structure means every onchain transaction reflects genuine equity exposure.

Atomic settlement removes the risk of partial fills entirely from the process. Trades either execute in full at the quoted price or do not go through.

Kraken announced the launch through its official X account, describing it as “the first unified execution layer for tokenized equities.” The exchange added that xChange delivers “TradFi liquidity. DeFi infrastructure. Always on.”

The platform operates 24/5, extending equity trading well beyond standard exchange hours. As a result, tokenized stocks function as always-on, programmable financial assets.

Introducing xChange from @xStocksfi — the first unified execution layer for tokenized equities ⚡️

Trade 70+ tokenized stocks onchain across Ethereum and Solana, with pricing anchored to real-world markets and atomic settlement.

TradFi liquidity. DeFi infrastructure. Always on.…

— Kraken (@krakenfx) March 5, 2026

Val Gui, General Manager of xStocks, described the platform’s purpose directly. “xChange is about redefining how equities trade in a digital-first world,” Gui stated.

He added that it “brings real-world market liquidity onchain and turns tokenized stocks into fully programmable, always-on assets.” Gui noted these assets are built to “power the next generation of global financial applications.”

xStocks Records Strong Growth Metrics Since June 2025 Since launching in June 2025, xStocks has surpassed $3.5 billion in total onchain transaction volume. The platform has also crossed $25 billion in total trading volume across exchanges.

These figures reflect growing demand for tokenized equities among DeFi users and traditional finance participants. The pace of growth points to measurable market adoption across both audiences.

Over $225 million in tokenized assets are currently held onchain. More than 80,000 unique onchain holders have participated in the broader ecosystem.

Tokenized equities are gaining traction as a distinct and recognized asset class. Adoption has continued expanding across multiple chains, platforms, and applications.

xChange builds on this momentum by introducing a unified execution layer across networks. The platform connects liquidity across Ethereum and Solana while tying pricing to traditional equity markets.

This connection supports tighter spreads and improved execution quality throughout the system. Onchain settlement and transferability remain fully intact at every step.

Rather than replacing existing DeFi liquidity models, xChange functions as an added layer. It improves price alignment and execution reliability across the broader ecosystem.

The outcome is a hybrid model that combines real-world equity market depth with blockchain-based trading infrastructure. xChange positions tokenized stocks as a functional bridge connecting two distinct financial worlds.

TL;DR:

Polygon launched the Agent CLI, an onchain toolkit for AI agents that includes wallets, payments, identity, and bridging in a single installation. Agents operate entirely in stablecoins, with no need to manage native gas tokens. Private keys remain outside the LLM context. The CLI includes native support for ERC-8004 and the x402 protocol. Polygon launched the Agent CLI, a command-line tool that unifies in a single installation everything an artificial intelligence agent needs to operate onchain: wallet creation, token sending and swapping, cross-chain bridging, identity registration, and stablecoin payments. The initiative aims to eliminate the infrastructure fragmentation that development teams face when trying to equip their agents with autonomous financial capabilities.

Until now, integrating an agent with the chain required assembling separately a wallet library, a gas abstraction layer, a swap API, a bridge API, and an identity system, each component coming from a different provider with no specific design for the threat models unique to agents. Polygon’s CLI replaces that fragmented stack with an integrated system that installs with a single npm command.

Polygon Proposes an Agent Economy on Onchain Rails The architecture is built on three layers. The first consists of smart contract wallets with session scope, per-token configurable spending limits, and a 24-hour expiration. Private keys never enter the language model’s context, which neutralizes prompt injection attack vectors aimed at extracting them.

The second is transaction orchestration through Polygon Trails, which handles routing, price discovery, and execution without the agent needing to know which DEX it uses in each operation. The third is native support for ERC-8004, an Ethereum standard for agent identity, co-authored by MetaMask, the Ethereum Foundation, Google, and Coinbase.

ERC-8004 and x402: The Standards Defining Agent-to-Agent Commerce The ERC-8004 standard allows each agent to register its identity onchain, accumulate portable reputation, and become discoverable by other agents and services. Complementarily, support for the x402 protocol enables micropayments per HTTP request to be executed directly in stablecoins, with no need to manage API keys or subscriptions. Agents pay exclusively for what they consume in each interaction.

Another important security element is the dry run mode enabled by default: before any transaction is broadcast to the network, Polygon presents a full preview of what will occur. In contexts where an agent can make thousands of decisions, that confirmation step keeps humans in control over what actually touches the chain. The toolkit is compatible with Claude, Openclaw, LangChain, and CrewAI, among other frameworks that support the use of this type of tool.

Journalist

Posted: March 5, 2026

Blockchain analytics firm Bubblemaps says it has identified a network of connected wallets that profited from betting on military strikes involving Iran on the crypto prediction market Polymarket.

In a thread published on X, Bubblemaps said it traced funds between several Polymarket accounts that placed highly accurate bets on U.S. and Israeli strikes. This raises questions about whether traders may have had advance knowledge of geopolitical events.

The findings follow earlier reports that six wallets collectively earned about $1.2 million by betting that the United States would strike Iran on 28 February, with many of the positions reportedly opened only hours before the attack.

Wallet tracing links Polymarket accounts According to Bubblemaps, a wallet identified as 0xa4eb, operating under the Polymarket username “nothingeverhappens911,” recently moved profits off the platform.

Tracing those funds led to another Polymarket account called “Skoobidoobnj,” with the connection established through a shared Binance deposit address.

Source: X

The second account allegedly made about $100,000 betting “yes” shortly before two separate military developments involving Iran in 2025.

Those events included:

13 June 2025: Israel launched an operation targeting Iranian assets. 21 June 2025: The United States reportedly joined the conflict with strikes on nuclear facilities at Fordow. Bubblemaps said the on-chain links suggest the accounts may be part of a broader cluster of traders using connected wallets.

Additional accounts identified The analytics firm said the Polymarket account “Skoobidoobnj” is also linked on-chain to two additional accounts suspected of placing trades at similarly timed intervals.

According to Bubblemaps:

One account allegedly earned about $65,000 betting on a U.S. strike on 28 February. Another reportedly made around $10,000 on predictions related to the 13 June Israeli strike. In total, the firm said four connected Polymarket accounts generated about $240,000 from bets predicting U.S. and Israeli military actions involving Iran.

Earlier $1.2M betting activity raised scrutiny The latest findings build on the earlier discovery that six recently funded wallets made roughly $1.2 million from the 28 February U.S. strike market.

Many of those wallets were reportedly funded within 24 hours of the event. They placed bets specifically on a strike occurring on that date.

The timing of the trades drew scrutiny from analysts and policymakers, with critics suggesting the activity could indicate traders acting on privileged information.

Prediction markets face growing attention Crypto-based prediction platforms such as Polymarket allow users to trade on the likelihood of real-world events ranging from elections to geopolitical conflicts.

While supporters argue that prediction markets can aggregate information efficiently, critics warn that they may create incentives for trading on sensitive or nonpublic information.

The Bubblemaps findings add to the ongoing debate over whether blockchain analytics could help identify suspicious trading behavior in decentralized prediction markets.

Final Summary Bubblemaps says on-chain tracing linked several Polymarket accounts that profited from betting on U.S. and Israeli strikes involving Iran. The findings follow earlier reports that six wallets earned about $1.2M from bets predicting a 28 February U.S. strike on Iran.

Hyperliquid price is approaching a key resistance level, and shrinking volatility suggests a possible breakout toward $35.

Summary

HYPE trades near $31 after slipping 5.7% in 24 hours but remains up 80% over the past year. Bollinger Bands are tightening, signaling a volatility squeeze that often precedes a major move. A breakout above $34 could push price toward $35, while losing $29 may expose the $26 support zone. At press time, Hyperliquid (HYPE) was trading at $31.24, down 5.7% in the past 24 hours. Over the last week, it moved between $26.22 and $33.33, ending roughly 7% higher. However, the token has decreased by roughly 10% per month.

HYPE continues to be one of the better-performing altcoins despite the recent decline. Over the past year, the token has increased by about 80%, despite difficulties in the larger cryptocurrency market.

Derivatives activity has cooled slightly. CoinGlass data shows that trading volume dropped 18% to about $1.25 billion, while open interest fell 7.5% to $1.21 billion, showing some traders closing their positions.

HYPE token fundamentals HYPE’s price is influenced by several structural factors.  The core of Hyperliquid’s ecosystem is perpetual futures trading, and the Assistance Fund for token buybacks receives about 97% of platform fees.

Increases in trading are directly correlated with increases in buybacks. For example, when trading volumes averaged $29 billion daily, $5.82 million in buybacks were generated, demonstrating a direct correlation between trading demand and token support.

Market sentiment has also been influenced by protocol upgrades. Permissionless perpetual markets were introduced by HIP-3, which produced a total volume of about $83 billion. 

HIP-4 proposal aims to launch outcome trading products, combining prediction markets, options, and binary-style contracts. These additions could expand platform activity if more retail or institutional traders participate.

Hyperliquid price technical analysis HYPE appears to be entering a compressed volatility phase. Bollinger Bands have tightened on the daily chart, which is frequently an indication of an impending big move.

The upper band, which has caused pullbacks in recent sessions, is being tested by the price.

Hyperliquid daily chart. Credit: crypto.news The structure of the market has improved. HYPE has formed a string of higher lows around $26 and $29 since late January, indicating that buyers are intervening earlier on dips. This outlook is also supported by momentum indicators. 

There is potential for more gains as the relative strength index is in the mid-50s and trending upward. Meanwhile, the mid-Bollinger Band has been offering dynamic support around $29.

A move toward $35 could ensue if HYPE breaks above $33–$34, with a possible extension to $38 if buying pressure increases. Deeper losses could retest the $26 base, and rejection at resistance could push the token back toward $29 on the downside.

The OKB token exploded over 41% to $120 just hours after the Intercontinental Exchange (ICE) announced an investment in OKX at a $25 billion valuation today, March 5. 

The news sent the exchange token vertical as both institutional and retail traders rush to ready themselves before the New York Stock Exchange possibly launches tokenized stock trading later this year.

The token’s price increase drove a 24-hour trading volume to over $470 million, which is approximately 1,657% more than the usual daily volume of around $44 million.

OKX’s OKB token has cooled off since its initial vertical surge on the news of the ICE announcement. Source: CoinMarketCap ICE, which is also the parent company of the New York Stock Exchange, will get a board seat at OKX as part of the investment.

The specific details of the investment are yet to be revealed, but Halder Rafique, OKX’s global managing partner, said it’s not just a “very casual investment”.

Token explosion signals market conviction OKB was trading around $77 before the announcement, running as high as $120, although the price has since cooled. A surge like that reflects a market conviction that ICE’s backing will make OKX a legitimate traditional finance (TradFi) to crypto bridge.

According to Fortune, this deal will allow OKX to enable users to trade tokenized stocks and derivatives listed on the New York Stock Exchange, which will most likely begin in the latter part of 2026. OKX will also provide live price feeds of crypto assets tradeable on its exchange to ICE as well.

The price action is also a recovery from OKB’s recent trading range, although it is still a fair way from its all-time high price above $220 in 2025.

While ICE has declined to specify investment terms or the exact stake acquired, the deal’s structure reveals strategic priorities beyond regular venture capital.

OKX will provide ICE with real-time crypto feeds (competing with data from Coinbase and Binance), while developing the infrastructure for OKX users to trade blockchain-wrapped NYSE stocks with benefits like lower gas fees and 24/7 trading.

OKX positioning for US expansion post-settlement The ICE partnership comes as part of OKX’s aggressive US market entry, following a troubling compliance history.

In February 2025, OKX reached a $500 million settlement with the Department of Justice after pleading guilty to operating an unlicensed money transmitting business. Two months after that, OKX relaunched US operations in California with a new CEO and compliance framework.

The timing of the ICE announcement also contrasts with Binance drawing renewed compliance scrutiny.

“We are the sober ones in the industry in many ways,” Rafique claimed, positioning OKX as the compliance-focused alternative to offshore competitors.

The OKX investment also represents ICE’s third major crypto move in four months, following a $2 billion Polymarket investment in October 2025, and a January announcement of tokenized securities trading infrastructure.

Nonetheless, with 21 million tokens in fixed supply and nearly a $2 billion market cap, OKB is now trading at a small fraction of the $88 billion valuation of BNB, the token of the world’s largest exchange.

That gap represents either a massive upside and market share capture if OKX delivers, or a sore reminder that announcements don’t guarantee growth.

OKX’s ability to convert the DOJ settlement stigma into trust and deliver on its second half of 2026 timeline will determine whether the surge was the beginning of consistent growth or just a temporary, speculative spike.

TLDR CleanSpark mined 568 BTC in February, bringing its year-to-date total to 1,141 BTC. CleanSpark sold 553.02 BTC during February at an average price of $66,279. The company increased its total Bitcoin holdings to 13,363 BTC by month-end. CleanSpark generated liquidity from sales while maintaining overall treasury growth. The February update detailed production, sales, and total Bitcoin reserves. CleanSpark expanded its Bitcoin treasury in February even as it sold most of its monthly production. The company reported 568 BTC mined and 553.02 BTC sold during the month. As a result, CleanSpark increased total holdings to 13,363 BTC by month-end.

CleanSpark Reports Higher Bitcoin Production and Sales CleanSpark mined 568 BTC in February, according to figures highlighted by ChainCatcher. This output lifted its year-to-date production to 1,141 BTC. The company disclosed these figures in its latest monthly update.

At the same time, CleanSpark sold 553.02 BTC during February. The company achieved an average sale price of $66,279 per BTC. Consequently, it generated cash while maintaining exposure to Bitcoin price movements.

CleanSpark confirmed that its treasury reached 13,363 BTC at the end of February. The company increased its holdings despite selling most of its newly mined coins. Therefore, net holdings rose during the reporting period.

The company balanced production, sales, and treasury growth within the same month. It used market strength to monetize output and support operations. Meanwhile, it preserved a large Bitcoin reserve on its balance sheet.

CleanSpark did not disclose any change in its mining capacity in the update. However, it focused on reporting production totals and treasury figures. The company maintained a clear breakdown of mined and sold amounts.

Bitcoin Treasury Strategy and February Figures Bitcoin traded near cycle highs during February. CleanSpark sold coins into this strength while continuing to mine new supply. This approach allowed the company to raise funds without reducing total holdings.

The company’s February sales totaled 553.02 BTC at an average price of $66,279. These transactions occurred during a period of elevated Bitcoin prices. As a result, CleanSpark converted a large share of production into liquidity.

Despite those sales, the company reported 13,363 BTC in treasury at month-end. This figure reflects an increase compared to prior holdings. CleanSpark confirmed the updated total in its production statement.

The company’s year-to-date mining output reached 1,141 BTC after February. February accounted for 568 BTC of that total. Therefore, the month represented roughly half of the year’s production so far.

CleanSpark structured its February activity around both cash generation and asset retention. It sold nearly all monthly output yet still expanded overall reserves. The company published these details as part of its routine operational reporting.

The update did not include commentary on future sales plans. Instead, CleanSpark presented production, sales, and treasury figures in a factual format. The company closed February with 13,363 BTC held on its balance sheet.

Ethereum derivatives markets saw a sharp bout of deleveraging over the past day, with total ETH contract open interest across major centralized exchanges falling 5.62% to 27.119 billion dollars, according to Coinglass data. ​

Summary

ETH total network contract open interest slid 5.62% in 24 hours to 27.119 billion dollars.​ Binance leads with 5.74 billion dollars in ETH OI, followed by Gate, Bybit, and OKX.​ ETH trades near 2,067 dollars, down about 3.65% on the day as leverage resets. According to data from Coinglass, the total open interest of Ethereum (ETH) contracts across the network has contracted by 5.62% in the past 24 hours, bringing the figure down to 27.119 billion dollars.

The decline signals a decisive round of risk reduction in the derivatives market, with traders closing or being forced out of leveraged positions as conditions turn more defensive. While granular liquidation figures were not provided, the magnitude of the move suggests a mix of voluntary deleveraging and margin-driven position exits rather than a purely organic rotation.

Binance remains the largest concentration point for ETH derivatives risk, now holding 5.74 billion dollars in open interest, while Gate registers 2.866 billion dollars, Bybit 2.059 billion dollars, and OKX 1.772 billion dollars. This clustering of leverage on a handful of venues means that order book dislocations or sudden funding shifts on these exchanges can quickly bleed into spot pricing. For basis and spread traders, the reset in open interest may open up cleaner arbitrage conditions after a period of elevated speculative positioning.​

Historically, single‑day pullbacks of this scale in open interest have often acted as either mid‑trend “cleanup” events or the first leg of a broader de‑risking cycle, depending on subsequent spot demand and funding dynamics. If funding normalizes and fresh spot buying emerges, the current move could be framed as a healthy clearing of excess leverage built up during prior rallies. However, if open interest continues to grind lower while spot remains under pressure, it would indicate that systematic and speculative capital are still in distribution mode.​

At press time, Ethereum is trading around 2,067 dollars, down approximately 3.65% over the past 24 hours, broadly echoing the scale of the derivatives drawdown. In the near term, traders are watching the 2,000‑dollar psychological level as key support; holding that zone while open interest stabilizes would support a consolidation narrative, whereas a decisive break lower alongside further OI contraction could signal an extension of the current downside phase.

The crypto market has always been driven by moments when a project transitions from anticipation to real trading activity. Before that point, everything exists as potential: presale participation, community momentum, and market speculation.

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Kyndryl securities between August 7, 2024 and February 9, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/KD.

Kyndryl Case Details

The Complaint alleges that throughout the Class Period, that Defendants made false and/or misleading statements and/or failed to disclose that:

      (1)    Kyndryl’s financial statements issued during the Class Period were materially misstated;
      (2)    Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls;
      (3)    as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and
      (4)    as a result, Defendants’ statements about Kyndryl’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

What's Next for Kyndryl Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/KD. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Kyndryl you have until April 13, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Kyndryl Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Kyndryl Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

Shareholders with losses of $50,000 or more are encouraged to contact the firm.

, /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORACLE CORPORATION (ORCL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 6, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Is The Lawsuit About?
The complaint filed alleges that, between June 12, 2025 and December 16, 2025, Defendants failed to disclose to investors that: (1) Oracle's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in revenue; (2) the Company's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects, among other concerns; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact:
Howard G. Smith, Esq.,
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Call us at: (215) 638-4847
Email us at: [email protected],
Visit our website at: www.howardsmithlaw.com.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com

SOURCE Law Offices of Howard G. Smith

 With 5,000 hail events and peak tornado months ahead, families urged to act now

, /PRNewswire/ -- The United States experiences roughly 100,000 thunderstorms each year — and about 10% escalate into severe storms capable of producing damaging hail, tornadoes and destructive wind. As peak tornado and hail season approaches, Mercury Insurance (NYSE/NYSE Texas: MCY) is urging homeowners and drivers to take preventive steps before the most volatile weather arrives.

Spring is peak season for severe thunderstorms, especially in Texas and Oklahoma, where tornado activity ramps up from April through June.

Texas led the nation in preliminary tornado reports in 2025 with 162 twisters, followed closely by Illinois with nearly 150 — a clear reminder of how frequently severe storms threaten homes and vehicles.

Damage can escalate quickly. A single tornado near Houston in November 2025 damaged more than 100 homes.

Risk isn't limited to the Plains. Georgia typically peaks from March through May, Illinois from April through June, and in the Northeast, New York and New Jersey see their highest tornado activity from June through August — extending the severe weather season well beyond spring.

"Severe weather can create significant damage in a matter of minutes, which is why preparation ahead of the season matters," said Steve Bennett, Head of Climate and Catastrophe Science at Mercury Insurance. "Reducing that risk often comes down to a few practical steps taken early — protecting vulnerable property, paying attention to forecasts, and understanding coverage before severe weather arrives."

Regional Risk: Where Severe Weather Hits Hardest

Texas & Central Plains: Hail Alley

Large hail can damage roofs, siding, solar panels and vehicles in minutes. Texas consistently leads the country in hail-related insurance claims.

Prepare by:

Parking vehicles under cover when severe weather is forecast Inspecting roofing materials and sealing vulnerable areas Trimming trees and securing loose outdoor property Midwest & Southeast: Tornadoes and Destructive Winds

High-wind events and tornadoes can cause structural roof failure, downed power lines and widespread debris damage.

Prepare by:

Reinforcing garage doors Securing patio furniture and outdoor equipment when severe weather is forecast Reviewing wind coverage limits in homeowners policies California: Atmospheric Rivers and Flood Risk

California's severe weather looks different from the tornado and hail threats common in Texas and the Plains. Much of the state's weather-related property risk is tied to atmospheric rivers during the cooler months, when heavy rain can drive flooding, runoff and debris flows — especially in and below wildfire burn scars. On average, about 75% of California's annual precipitation falls from November through March.

Prepare by:

Clearing gutters and storm drains Moving vehicles to higher ground during flood watches Evaluating separate flood insurance coverage, as standard homeowners policies do not cover flood damage Vehicles at Elevated Risk During Spring Storms

Hail, falling debris and flash flooding are leading drivers of spring auto claims. Comprehensive coverage typically protects against these perils. "Vehicles are often exposed during fast-moving storm systems," Bennett said. "Covered parking, paying attention to weather alerts and understanding your coverage can significantly reduce both disruption and out-of-pocket costs." Why Acting Before the Storm Matters

Severe storm losses have steadily increased due to expanding development in high-risk areas and rising material and labor costs. Proactive maintenance and risk awareness can help:

Reduce claim severity Prevent secondary water intrusion damage Shorten recovery timelines "Insurance helps families recover," Bennett added. "But resilience begins before the first weather warning."

For storm preparation resources and coverage guidance, visit the Mercury Blog.

About Mercury Insurance

Mercury Insurance (NYSE: MCY) is a multiple-line insurance carrier predominantly offering personal auto, homeowners, renters and commercial insurance through a network of independent agents in Arizona, California, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas and Virginia, as well as auto insurance in Florida. Mercury writes other lines of insurance in various states, including commercial, business owners and business auto, landlord, home-sharing, ride-hailing and mechanical protection insurance.

Since 1962, Mercury has provided customers with tremendous value for their insurance dollar by pairing ultra-competitive rates with excellent customer service, through more than 4,200 employees and a network of more than 6,340 independent agents in 11 states. Mercury has earned an "A" rating from A.M. Best, as well as "Best Auto Insurance Company" designations from Forbes and Insure.com. For more information visit www.MercuryInsurance.com or follow the company on X, Instagram or Facebook.

Media interested in receiving updates from Mercury can learn more at the Mercury Newsroom.

SOURCE Mercury Insurance

, /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS).

IF YOU SUFFERED A LOSS ON YOUR VARONIS INVESTMENTS, CLICK HERE BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About?
The complaint filed alleges that, between February 4, 2025 and October 28, 2025, Defendants failed to disclose to investors that: (1) Varonis was ill-equipped to continue its ARR growth trajectory without maintaining a significantly high rate of quarterly conversions; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email:  [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased. 

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:

Glancy Prongay Wolke & Rotter LLP, 
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email:  [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

SOURCE Glancy Prongay Wolke & Rotter LLP

, /PRNewswire/ -- OneIM Acquisition Corp. (Nasdaq: OIMAU) (the "Company") announced today that, commencing March 6, 2026, the holders of the units issued in the Company's initial public offering (the "Units"), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the "Class A Ordinary Shares"), and one-sixth of one redeemable warrant of the Company (each, a "Warrant"), with each whole Warrant entitling the holder to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols "OIM" and "OIMAW," respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol "OIMAU."

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About OneIM Acquisition Corp.

The Company is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with a target in industries or sectors in which the Company's management team and its affiliates have considerable knowledge and where the Company believes it has the ability to capture asymmetric risk/reward potential.

The Company's management team is led by Ioannis Pipilis, Chief Executive Officer and a member of the Board of Directors of the Company (the "Board"), and Grigorios Kapenis, Chief Financial Officer and a member of the Board. The Board also includes independent directors Mark DiPaolo and Antony Sheriff.

Please visit https://www.oneimacquisitioncorp.com/ for more information.

FORWARD-LOOKING STATEMENTS

This press release may include, and oral statements made from time to time by representatives of the Company may include, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the Securities and Exchange Commission ("SEC"). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contact

OneIM Acquisition Corp.
Ioannis Pipilis, Chief Executive Officer
[email protected]

Media Contact

Greenbrook
Bree Taylor / Ksenia Galouchko
[email protected]

SOURCE OneIM Acquisition Corp.

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BATH & BODY WORKS, INC. (BBWI), CLICK HERE BEFORE MARCH 16, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

What Is The Lawsuit About?
The complaint filed alleges that, between June 4, 2024 and November 19, 2025, Defendants failed to disclose to investors: (1) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (2) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; (3) as a result, the Company was unlikely to meet its own previously issued financial guidance; (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYNDRYL HOLDINGS, INC. (KD), CLICK HERE BEFORE APRIL 13, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

What Is The Lawsuit About?
The complaint filed alleges that, between August 7, 2024 and February 9, 2026, Defendants failed to disclose to investors that: (1) Kyndryls financial statements issued during the Class Period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) common stock between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”).

IF YOU SUFFERED A LOSS ON YOUR NUSCALE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?
On November 6, 2025, after market hours, NuScale disclosed that the Company’s general and administrative expenses had increased more than 3,000%, to $519 million during its third fiscal quarter compared to $17 million in the prior year period. The surge was largely due to the Company’s payment of $495 million to ENTRA1 Energy LLC for its Tennessee Valley Authority agreement. As a result, NuScale’s quarterly net loss rose to $532 million, up from $46 million in the prior year period.

Following the Company’s earnings announcement, analysts at Guggenheim Securities published a report stating that ENTRA1 was a “3-year old company that has never built, financed or operated anything” and that its available information revealed nothing “regarding the company’s history, management team, size or capitalization.” The report further stated that a “more accurate description” of ENTRA1 would be “that it is an entity supporting the activities of a single individual, specifically [its CEO and Chairman, Wadie Habboush].”

On this news, NuScale’s stock price fell $4.03, or 12.4%, over two consecutive trading days to close at $28.43 per share on November 10, 2025, thereby injuring investors.

What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) ENTRA1 had never built, financed, or operated any significant projects—let alone projects in the highly technical and complicated field of nuclear power generation—during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NuScale Power Modules, and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; (4) as a result, NuScale's commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired NuScale common stock during the Class Period, you may move the Court no later than April 20, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”).

IF YOU SUFFERED A LOSS ON YOUR CORCEPT INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?
On December 31, 2025, Corcept announced the U.S. Food and Drug Administration (“FDA”) had issued a Complete Response Letter (“CRL”), declining to approve the Company’s New Drug Application (“NDA”) for relacorilant as a treatment for patients with hypercortisolism, stating that the FDA had “concluded it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness.” The Company stated it was “surprised and disappointed by this outcome.”

On this news, Corcept’s stock price fell $35.40 per share, or 50.42%, to close at $34.80 per share on December 31, 2025.

Then, on January 30, 2026, the FDA published an updated CRL regarding Corcept’s relacorilant NDA. The letter revealed that “[d]uring the pre-submission meetings, [the FDA] informed [Corcept] on several occasions of [its] concerns about the adequacy of the clinical development program to assess the effect of relacorilant” and “to expect significant review issues if [Corcept] were to submit [its] application.”

What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the FDA had told Corcept that it had concerns about the adequacy of the program assessing relacorilant’s effectiveness in treating hypertension in patients with hypercortisolism, including the design of its pivotal “GRACE” trial study; (2) the FDA had further told Corcept to expect significant issues with the review if Corcept was to submit the NDA; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Corcept common stock during the Class Period, you may move the Court no later than April 21, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

An updated edition of the Jan. 16, 2026, article.

Sin stocks refer to shares of companies that operate in industries often considered socially controversial, such as alcohol, tobacco, gambling and sometimes firearms or cannabis. Despite the ethical debate surrounding them, these businesses tend to generate steady demand and strong cash flows, making them a notable segment of the equity market.

Sin stock investing works much like traditional stock investing. Investors purchase shares of companies whose products fall within these categories and seek returns through capital appreciation and dividends. Major players in these industries include tobacco giant Altria Group (MO - Free Report) , beverage leader Diageo Plc (DEO - Free Report) and leading casino operators. Because their products often have loyal consumer bases, these companies tend to maintain relatively stable sales even amid economic downturns.

However, investing in sin stocks comes with certain risks. These industries face strict government regulations, higher taxes, legal scrutiny and advertising restrictions. In addition, some institutional investors avoid these companies due to environmental, social and governance (ESG) considerations, which can influence valuations and investor sentiment.

Why Some Investors Choose Sin StocksOne reason investors consider sin stocks is their defensive characteristics. Demand for products like alcohol and cigarettes typically remains resilient regardless of economic cycles. Companies operating in industries such as alcohol, tobacco and gambling often benefit from consistent consumer demand. This stability often translates into consistent revenue streams and attractive dividend payouts. Many sin-stock companies also benefit from strong brand loyalty and pricing power, which can support long-term profitability.

Another reason investors choose sin stocks is their high profitability and dividend potential. These companies often enjoy strong pricing power and relatively predictable cash flows, enabling them to return a significant portion of profits to shareholders through dividends and share buybacks. As a result, sin stocks are sometimes viewed as defensive investments within a diversified portfolio.

Additionally, the growing focus on ESG investing has led many institutional funds to avoid these sectors. This reduced participation can occasionally leave sin stocks undervalued, creating opportunities for investors who prioritize financial returns over ethical considerations.

Trends in Sin Stock SectorsSin stock sectors are evolving as consumer behavior, technology and regulations reshape traditional industries such as alcohol, tobacco and gambling. One major trend is product innovation and diversification. Tobacco companies are shifting toward reduced-risk products like vaping devices, heated tobacco and smokeless alternatives to address health concerns and declining cigarette consumption.

Another key trend is premiumization in the alcohol industry. Consumers are increasingly opting for premium, craft and specialty beverages, while demand for low and no-alcohol drinks is also growing. This shift allows companies to maintain strong pricing power and expand profit margins.

The digital transformation of gambling is also reshaping the sector. Online betting, mobile gaming platforms and legalized sports wagering are creating revenue streams and attracting younger consumers, significantly expanding the market.

At the same time, regulatory changes and higher “sin taxes” remain a defining factor for these industries, influencing profitability and stock performance. Governments often impose higher taxes on tobacco, alcohol and gaming to discourage consumption while raising revenues. Overall, while sin stock sectors face regulatory scrutiny, innovation, digital expansion and shifting consumer preferences continue to shape their long-term growth prospects.

If you are looking to capitalize on this trend, our Sin Stocks Screen makes it easy to identify high-potential stocks such as Monarch Casino & Resort (MCRI - Free Report) , Philip Morris International (PM - Free Report) and Constellation Brands, Inc. (STZ - Free Report) .

Explore 36 cutting-edge investment themes with Zacks Thematic Investing Screens and uncover your next big opportunity.

Monarch Casino presents a solid long-term investment case, driven by its premium regional resort strategy and disciplined operations. The company focuses on enhancing guest experiences through property upgrades, modern gaming amenities and high-quality hospitality offerings, helping strengthen its competitive position in key markets.

Management continues to prioritize targeted marketing, operational efficiency and reinvestment in its flagship properties to attract higher-value customers and boost spending per visit. Its concentrated portfolio allows greater control over service quality and cost management. With consistent property improvements and a focus on premium experiences, the Zacks Rank #2 (Buy) company is well-positioned to sustain visitation growth and generate stable cash flows over the long term. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Philip Morris offers a strong long-term investment case, driven by its transformation toward a smoke-free future. The company holds a leading global position, supported by powerful brands, extensive distribution and strong pricing power. Its strategy focuses on expanding reduced-risk products, such as heated tobacco and nicotine pouches, which are gaining traction among adult consumers.

Management continues to invest in innovation, research and brand development to accelerate the adoption of these next-generation products across global markets. With strong cash generation and growing consumer acceptance of smoke-free alternatives, Philip Morris is well-positioned to sustain long-term growth and deliver durable shareholder value. The company currently sports a Zacks Rank #2.

Constellation Brands’ fundamental strength lies in its dominant position in the U.S. high-end beer category, supported by industry-leading brands such as Modelo, Corona and Pacifico. Despite a pressured consumer backdrop, STZ continues to outperform the beer category and gain market share across 49 of 50 states, underscoring strong brand equity and customer loyalty. The company’s strategy emphasizes pricing discipline, cost-saving initiatives and optimized price-pack architecture, which have helped sustain the beer operating margin, even amid volume and cost headwinds.

STZ’s 7 million hectoliter capacity expansion through fiscal 2028, modular capital deployment and focus on distribution gains support structural growth. Strong cash flows and operational flexibility reinforce its ability to drive durable earnings and shareholder returns. The company currently has a Zacks Rank #2.

Key Takeaways CAH posted strong fiscal Q2 as pharma and specialty revenue rose 19% to $61B and segment profit jumped 29%.CAH's specialty sales to exceed $50B in fiscal 2026, driven by oncology, urology and specialty distribution.CAH's Nuclear & Precision Health, at-Home and OptiFreight units saw 34% revenue and 52% profit growth. Cardinal Health (CAH - Free Report) is well-positioned for continued growth, thanks to the expansion of its speciality portfolio. The firm delivered strong fiscal second-quarter results, fueled by robust demand in pharmaceutical distribution and accelerating specialty services. Growth in theranostics, at-home solutions and logistics businesses, alongside improving medical segment performance, continues to strengthen CAH’s long-term earnings outlook.

This Zacks Rank #2 (Buy) company’s shares have gained 49.2% in the past six months compared with the industry’s 23.3% growth. The S&P 500 has jumped 6.4% during the same time frame.

The leading provider of healthcare services and products has a market capitalization of $53.26 billion. It projects 15% growth over the next five years and expects to witness continued improvement in its business going forward. Cardinal Health’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 9.3%.

Image Source: Zacks Investment Research

Let’s delve deeper.

UpsidesStrong Momentum in Pharmaceutical and Specialty Solutions: Cardinal Health delivered robust growth in its core Pharmaceutical and Specialty Solutions segment, with revenue rising 19% to $61 billion and segment profit increasing 29% in the second quarter of fiscal 2026. Growth was supported by strong demand across brand, specialty and generics, along with contributions from specialty distribution, MSO platforms and biopharma services. Management highlighted that specialty revenues are expected to exceed $50 billion in fiscal 2026, underscoring the company’s successful pivot toward higher-margin specialty therapies, such as oncology and urology. This expansion strengthens Cardinal Health’s competitive positioning in the fast-growing specialty pharmaceutical ecosystem.

High-Growth Adjacent Businesses Drive Profit Diversification: Cardinal Health’s “Other” growth businesses — Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight Logistics — delivered 34% revenue growth and 52% profit growth in the fiscal second quarter. Demand was fueled by structural healthcare trends, including theranostics adoption, home-based care expansion and supply chain optimization. Theranostics alone generated more than 30% revenue growth, supported by a pipeline of more than 70 products. These segments provide faster growth and higher margins compared with traditional distribution, allowing Cardinal Health to diversify earnings streams and reduce reliance on its low-margin core pharmaceutical distribution business.

Improving Profitability in the GMPD Segment Turnaround: Cardinal Health’s Global Medical Products and Distribution (GMPD) segment showed tangible progress in its turnaround strategy, with segment profit rising from $18 million to $37 million year over year. The improvement reflects operational restructuring, cost optimization and stronger demand for Cardinal Health branded products, which grew 10% in the United States. Management also emphasized improved service levels and supply chain efficiency following manufacturing and logistics investments. If these operational gains persist, the GMPD business could transition from a long-standing drag on earnings to a modest contributor to profitability and margin expansion.

DownsidesProfit Growth Moderation Expected in the Second Half: Despite strong first-half results in fiscal 2026, Cardinal Health expects profit growth in the Pharma segment to moderate to mid-teens levels in the second half. The slowdown reflects difficult comparisons from onboarding $10 billion in new customers last year and the anniversary of prior acquisitions. While demand remains healthy, the normalization of these one-time growth drivers could temper earnings momentum. Investors may view this deceleration as a signal that recent growth levels were partly driven by temporary tailwinds rather than purely sustainable organic expansion.

Tariffs and Supply Chain Costs Weigh on Medical Segment: The GMPD segment continues to face external cost pressures, particularly from tariffs affecting medical product sourcing. Although cost optimization initiatives helped offset some of the impact, tariffs still represented a net headwind to segment profitability during the quarter. Given the global nature of medical product manufacturing and sourcing, persistent geopolitical trade policies or supply chain disruptions could increase procurement costs, compress margins and limit the pace of profitability recovery within the GMPD turnaround plan.

Limited Margin Expansion in Core Distribution Model: Cardinal Health’s pharmaceutical distribution business, while large and stable, structurally operates with thin margins and high volume dependence. Management acknowledged that major drug categories such as GLP-1 therapies contribute meaningfully to revenue growth but have a limited impact on underlying profitability. This reflects the inherent economics of pharmaceutical distribution, where scale drives revenue but margins remain compressed. As a result, sustained earnings expansion increasingly depends on specialty services and adjacent businesses rather than the core distribution segment alone.

Estimate TrendCardinal Health has been witnessing an improving estimate revision trend for 2026. Over the past 30 days, the Zacks Consensus Estimate for earnings per share (EPS) has improved 2.7% to $10.31.

The Zacks Consensus Estimate for the fiscal 2026 third-quarter revenues is pegged at $62.42 billion, indicating a 13.7% improvement from the year-ago reported number. The Zacks Consensus Estimate for EPS is pinned at $2.80, implying a year-over-year gain of 19.2%.

Other Stocks to ConsiderSome other top-ranked stocks from the same medical industry are Globus Medical (GMED - Free Report) , Pacific Biosciences of California (PACB - Free Report) and Edwards Lifesciences (EW - Free Report) .

Globus Medical, sporting a Zacks Rank #1 (Strong Buy) at present, reported fourth-quarter 2025 adjusted EPS of $1.28, beating the Zacks Consensus Estimate by 20.8%. Revenues of $826 million surpassed the Zacks Consensus Estimate by 4.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.

GMED has an estimated long-term earnings growth rate of 9.6% compared with the industry’s 14% rise. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 13.2%.

Pacific Biosciences of California, currently flaunting a Zacks Rank of 1, reported a fourth-quarter 2025 adjusted loss per share of 12 cents, which surpassed the Zacks Consensus Estimate by 36.8%. Revenues of $45 million beat the Zacks Consensus Estimate by 9.4%.

PACB has an estimated earnings decline rate of 1.9% against the industry’s 11.4% improvement. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.7%.

Edwards Lifesciences, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter fiscal 2026 adjusted EPS of 58 cents, which missed the Zacks Consensus Estimate by 6.5%. Revenues of $1.57 billion beat the Zacks Consensus Estimate by 2%.

EW has an estimated long-term earnings growth rate of 12.9% compared with the industry’s 14% rise. The company beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 5.5%.

2.5K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Shares of Silence Therapeutics PLC Sponsored ADR (SLN - Free Report) have gained 34.4% over the past four weeks to close the last trading session at $5.78, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $32.8 indicates a potential upside of 467.5%.

The mean estimate comprises five short-term price targets with a standard deviation of $26.16. While the lowest estimate of $4.00 indicates a 30.8% decline from the current price level, the most optimistic analyst expects the stock to surge 1197.6% to reach $75.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

But, for SLN, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why SLN Could Witness a Solid UpsideThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The Zacks Consensus Estimate for the current year has increased 14.5% over the past month, as one estimate has gone higher compared to no negative revision.

Moreover, SLN currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much SLN could gain, the direction of price movement it implies does appear to be a good guide.

Verano stock has surged more than 40% in a year amid U.S. marijuana rescheduling optimism, but revenue headwinds and rising competition may keep investors cautious.